Please use this identifier to cite or link to this item:
|Title:||New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity.|
|Citation:||CHEM COMMUN (CAMB), 2004 (15), pp. 1696-1697|
|Abstract:||The first biologically active non-planar analogues of the toxic anti-cancer agent, fascaplysin, have been produced; we present the design, synthesis and biological activity of three tryptamine derivatives.|
|Appears in Collections:||Published Articles, Dept. of Chemistry|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.